<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04657835</url>
  </required_header>
  <id_info>
    <org_study_id>20CH027</org_study_id>
    <secondary_id>2020-A01632-37</secondary_id>
    <nct_id>NCT04657835</nct_id>
  </id_info>
  <brief_title>Assessment of Atrial Cardiomyopathy Using MRI as a Predictor of Cardiac Post-Operative Atrial Fibrillation After Cardiac Surgery.</brief_title>
  <acronym>IRM-FAPO</acronym>
  <official_title>Assessment of Atrial Cardiomyopathy Using MRI as a Predictor of Cardiac Post-Operative Atrial Fibrillation After Cardiac Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Saint Etienne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Saint Etienne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      After cardiac surgery, there is a high prevalence of postoperative atrial fibrillation&#xD;
      (POAF). However, its diagnostic and therapeutic management is poorly codified.&#xD;
&#xD;
      This pathology is caused by atrial abnormalities which form the concept of atrial&#xD;
      cardiomyopathy.&#xD;
&#xD;
      New tools affording to itemize the atrial cardiomyopathy are needed. Indeed, current tools,&#xD;
      as echocardiography and electrocardiogram are relevant but only lead to a raw evaluation of&#xD;
      the atrial cardiomyopathy. MRI, because of the assessment of the atrial fibrosis by late&#xD;
      gadolinium assessment (LGE) and 4D flow magnetic resonance imaging (MRI) could be relevant to&#xD;
      specify the atrial cardiomyopathy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to evaluate the atrial cardiomyopathy, assessed by magnetic resonance&#xD;
      imaging (MRI), as a predictor of postoperative atrial fibrillation (POAF) after with coronary&#xD;
      artery bypass graft surgery .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2022</start_date>
  <completion_date type="Anticipated">August 2024</completion_date>
  <primary_completion_date type="Anticipated">August 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Analysis of the occurrence of Post-Operative Atrial Fibrillation</measure>
    <time_frame>7 days after the surgery</time_frame>
    <description>Measured by a continuous recording of cardiac electrical activity during 7 days after the surgery.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analysis of the occurrence of Atrial Fibrillation</measure>
    <time_frame>Year: 1</time_frame>
    <description>Analysis of the occurrence of Atrial Fibrillation evaluated during the first year post-operatively.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anatomopathological parameters for the evaluation of tissue fibrosis</measure>
    <time_frame>Year: 1</time_frame>
    <description>Analysis Anatomopathological parameters for the evaluation of tissue fibrosis evaluated by cardiac muscle biopsy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of Atrial Heart Disease by cardiac Magnetic Resonance Imaging (MRI) results</measure>
    <time_frame>Before the surgery</time_frame>
    <description>Assessment of Atrial Heart Disease by cardiac Magnetic Resonance Imaging (MRI) results to find a correlation with Post-Operative Atrial Fibrillation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between biological parameter Interleukin 1 (IL-1) and occurrence of Post-Operative Atrial Fibrillation</measure>
    <time_frame>Years: 2</time_frame>
    <description>Measured by blood sample results.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation between biological parameter TNF-α and occurrence of Post-Operative Atrial Fibrillation</measure>
    <time_frame>Years: 2</time_frame>
    <description>Measured by blood sample results.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Coronary Artery Bypass Grafting</condition>
  <arm_group>
    <arm_group_label>Coronary Artery Bypass Grafting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient with indication of Coronary Artery Bypass Grafting will be included. They will have:&#xD;
before surgery : cardiac Magnetic Resonance Imaging (MRI), Blood sample&#xD;
during surgery : Cardiac muscle biopsy&#xD;
after surgery : Holter-electrocardiogram (ECG), medical examination</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cardiac Magnetic Resonance Imaging (MRI)</intervention_name>
    <description>Cardiac magnetic resonance imaging (MRI) will be realized before Coronary Artery Bypass Grafting for assess atrial cardiomyopathy.</description>
    <arm_group_label>Coronary Artery Bypass Grafting</arm_group_label>
    <other_name>4D flow Magnetic Resonance Imaging with Late Gadolinium Enhancement</other_name>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Blood sample</intervention_name>
    <description>Blood sample will be realized (4 tubes of 4ml blood, 16ml in total) before Coronary Artery Bypass Grafting.</description>
    <arm_group_label>Coronary Artery Bypass Grafting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cardiac muscle biopsy</intervention_name>
    <description>Cardiac muscle biopsy will be realized during Coronary Artery Bypass Grafting.</description>
    <arm_group_label>Coronary Artery Bypass Grafting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Holter-electrocardiogram (ECG)</intervention_name>
    <description>Holter-electrocardiogram (ECG) will be realized 1 year after Coronary Artery Bypass Graftin during 3 days to diagnose the occurrence of atrial fibrillation.</description>
    <arm_group_label>Coronary Artery Bypass Grafting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>medical examination</intervention_name>
    <description>medical examination will be realized 1 year after Coronary Artery Bypass Graftin. Theses datas will collected: events during the follow-up year and evaluation of the Holter-electrocardiogram result.</description>
    <arm_group_label>Coronary Artery Bypass Grafting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Indication for surgical myocardial revascularization by coronary artery bypass&#xD;
&#xD;
          -  Patient affiliated or entitled to a social security scheme&#xD;
&#xD;
          -  Informed consent for participation in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindication to cardiac MRI (Severe Kidney disease, Allergy to gadoliniumn, ...)&#xD;
&#xD;
          -  History of Atriale Fibrillation (AF)&#xD;
&#xD;
          -  Indication of cardiac valve surgery concomitantly with Coronary Artery Bypass Grafting&#xD;
             (CABG).&#xD;
&#xD;
          -  pregnant or breast-feeding women&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Baptiste GUICHARD, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU SAINT-ETIENNE</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Baptiste GUICHARD, MD</last_name>
    <phone>(0)4 77 82 30 77</phone>
    <phone_ext>+33</phone_ext>
    <email>j.baptiste.guichard@chu-st-etienne.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Fleur PETIT, CRA</last_name>
    <phone>(0)4.77.82.95.58</phone>
    <phone_ext>+33</phone_ext>
    <email>Fleur.petit@chu-st-etienne.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU Saint-Etienne</name>
      <address>
        <city>Saint-Étienne</city>
        <country>France</country>
      </address>
    </facility>
    <investigator>
      <last_name>Jean-Baptiste Guichard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Antoine Da Costa, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kasra Azarnoush, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 24, 2020</study_first_submitted>
  <study_first_submitted_qc>December 1, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2020</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Post Operative Atrial Fibrillation</keyword>
  <keyword>magnetic resonance imaging</keyword>
  <keyword>Coronary Artery Bypass Grafting (CABG)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

